Stericycle Inc. (NASDAQ:SRCL) had its price objective trimmed by Robert W. Baird from $99.00 to $85.00 in a research report released on Friday morning. The brokerage currently has a neutral rating on the stock.
Other analysts also recently issued reports about the stock. Zacks Investment Research upgraded shares of Stericycle from a hold rating to a buy rating and set a $119.00 price objective on the stock in a research report on Thursday, July 21st. Jefferies Group restated a buy rating and set a $140.00 price target on shares of Stericycle in a research report on Monday, July 18th. Wellington Shields downgraded shares of Stericycle from an accumulate rating to a hold rating in a research report on Friday, July 29th. Imperial Capital dropped their price target on shares of Stericycle from $100.00 to $95.00 and set an in-line rating on the stock in a research report on Thursday, May 26th. Finally, Macquarie began coverage on shares of Stericycle in a research report on Thursday, August 25th. They set a neutral rating and a $96.00 price target on the stock. Three analysts have rated the stock with a sell rating, eleven have assigned a hold rating and three have assigned a buy rating to the stock. Stericycle currently has an average rating of Hold and an average price target of $104.95.
Stericycle (NASDAQ:SRCL) opened at 81.53 on Friday. The company’s 50 day moving average is $83.25 and its 200 day moving average is $101.19. Stericycle has a 52 week low of $76.76 and a 52 week high of $151.57. The stock has a market cap of $6.93 billion, a P/E ratio of 28.70 and a beta of 0.27.
Stericycle (NASDAQ:SRCL) last issued its quarterly earnings data on Thursday, July 28th. The company reported $1.18 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $1.18. The firm had revenue of $891.60 million for the quarter, compared to the consensus estimate of $910.29 million. Stericycle had a net margin of 7.22% and a return on equity of 14.84%. Stericycle’s quarterly revenue was up 24.6% compared to the same quarter last year. During the same period last year, the firm posted $1.14 EPS. Equities analysts predict that Stericycle will post $4.67 earnings per share for the current year.
In other news, Director Mark C. Miller sold 24,665 shares of Stericycle stock in a transaction that occurred on Friday, July 1st. The shares were sold at an average price of $104.55, for a total value of $2,578,725.75. Following the transaction, the director now directly owns 229,449 shares of the company’s stock, valued at $23,988,892.95. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP John P. Schetz sold 1,398 shares of Stericycle stock in a transaction that occurred on Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total transaction of $114,426.30. Following the completion of the transaction, the executive vice president now directly owns 1,088 shares in the company, valued at $89,052.80. The disclosure for this sale can be found here. 3.30% of the stock is currently owned by insiders.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in SRCL. Norges Bank purchased a new position in Stericycle during the fourth quarter valued at $76,432,000. Chevy Chase Trust Holdings Inc. increased its position in Stericycle by 5.2% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 74,656 shares of the company’s stock valued at $9,421,000 after buying an additional 3,659 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund increased its position in Stericycle by 15.6% in the first quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 16,521 shares of the company’s stock valued at $2,085,000 after buying an additional 2,227 shares during the period. Exxonmobil Investment Management Inc. TX increased its position in Stericycle by 8.6% in the first quarter. Exxonmobil Investment Management Inc. TX now owns 20,692 shares of the company’s stock valued at $2,611,000 after buying an additional 1,643 shares during the period. Finally, PGGM Investments increased its position in Stericycle by 5.1% in the first quarter. PGGM Investments now owns 69,153 shares of the company’s stock valued at $8,726,000 after buying an additional 3,377 shares during the period. 92.80% of the stock is currently owned by institutional investors and hedge funds.
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.